title: Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.
abstract: Recombinant adenoviruses are attractive vehicles for liver-directed gene therapy because of the high efficiency with which they transfer genes to hepatocytes in vivo. First generation recombinant adenoviruses deleted of E1 sequences also express recombinant and early and late viral genes, which lead to development of destructive cellular immune responses. Previous studies indicated that class I major histocompatibility complex (MHC)-restricted cytotoxic T lymphocytes (CTLs) play a major role in eliminating virus-infected cells. The present studies utilize mouse models to evaluate the role of T-helper cells in the primary response to adenovirus-mediated gene transfer to the liver. In vivo ablation of CD4+ cells or interferon gamma (IFN-gamma) was sufficient to prevent the elimination of adenovirus-transduced hepatocytes, despite the induction of a measurable CTL response. Mobilization of an effective TH1 response as measured by in vitro proliferation assays was associated with substantial upregulation of MHC class I expression, an effect that was prevented in IFN-gamma-deficient animals. These results suggest that elimination of virus-infected hepatocytes in a primary exposure to recombinant adenovirus requires both induction of antigen-specific CTLs as well as sensitization of the target cell by TH1-mediated activation of MHC class I expression.
authors.affiliation: Institute for Human Gene Therapy, University of Pennsylvania, PA, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Yang
authors.forename: Z
authors.initials: Z
authors.lastname: Xiang
authors.forename: H C
authors.initials: HC
authors.lastname: Ertl
authors.forename: J M
authors.initials: JM
authors.lastname: Wilson
mesh_terms: D000260:Adenoviruses, Human / Q000235:genetics* / Q000276:immunology*; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D015316:Genetic Therapy; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D007111:Immunity, Cellular; D007371:Interferon-gamma / Q000378:metabolism / Q000494:pharmacology*; D008099:Liver / Q000276:immunology / Q000382:microbiology; D051379:Mice; D008810:Mice, Inbred C57BL; D008954:Models, Biological; D011995:Recombination, Genetic; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D015854:Up-Regulation
chemical_list: D015395:Histocompatibility Antigens Class I; D007371:Interferon-gamma